WALTHAM, Mass., Aug. 23, 2018 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq:NURO) today announced it will be a presenting
company at the 20th Annual Global Investment Conference, sponsored by H.C. Wainwright & Co.,
LLC. The conference is being held on September 4 - 6, 2018, at The St. Regis New York in New York
City. Shai N. Gozani, M.D., Ph.D., President and CEO of NeuroMetrix, will provide an overview of the Company's business
during the live presentation and will be available to participate in one-on-one meetings with investors who are registered to
attend the conference.
The NeuroMetrix presentation is scheduled for Thursday, September 6, 2018 at 4:40 PM Eastern time. A live
audio webcast will be available on the investor relations section of the corporate website, www.NeuroMetrix.com. This webcast will be archived after the live event.
About
NeuroMetrix is an innovation driven healthcare company combining neurostimulation and digital medicine to address
chronic health conditions including chronic pain, sleep disorders, and diabetes. The company's lead product is Quell®,
an over-the-counter wearable therapeutic device for chronic pain. The company also markets DPNCheck®, a rapid
point-of-care test for diabetic neuropathy, which is the most common long-term complication of Type 2 diabetes. For more
information, please visit NeuroMetrix.com.
NeuroMetrix, Inc.
Thomas T. Higgins, 781-314-2761
SVP and Chief Financial Officer
Neurometrix.ir@neurometrix.com
Source: NeuroMetrix, Inc.
